CSF1 and breast carcinoma: Jang et al. found that treatment of the murine 4T1 breast cancer cells with the anti-tumor drug epigallocatechin gallate (EGCG) decreased the expression of macrophage colony-stimulating factor 1 (CSF-1) and CC-chemokine ligand 2 (CCL2), which inhibits TAM infiltration and migration [142].